Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.

Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.

Item
http://www.wikidata.org/entity/Q38461061
An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sitesMucosal vaccine delivery: Current state and a pediatric perspectiveIs There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?Modes of Action for Mucosal Vaccine Adjuvants.Current state and challenges in developing oral vaccines.Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.Noninvasive vaccination against infectious diseases.Immunogenicity of enterotoxigenic Escherichia coli outer membrane vesicles encapsulated in chitosan nanoparticles.Microcrystalline Cellulose for Delivery of Recombinant Protein-Based Antigen against Erysipelas in Mice.Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract.
P2860

Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.

Item
http://www.wikidata.org/entity/Q38461061
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intranasal and oral vaccinatio ...... es and formulation strategies.
@en
type
label
Intranasal and oral vaccinatio ...... es and formulation strategies.
@en
prefLabel
Intranasal and oral vaccinatio ...... es and formulation strategies.
@en
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Intranasal and oral vaccinatio ...... es and formulation strategies.
@en
P2093
P275
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932